Healixia is the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy.

Become a member

Healixia events

  1. link Linked'In.jpg
    01 February '22

    Healixia New Year's Event WILL NOT TAKE PLACE

    Due to COVID, our planned New Year's Event will not take place.

  2. j-kelly-brito-PeUJyoylfe4-unsplash.jpg
    22 February '22

    Webinar - Innovation in Healthcare: Current and future trends

    Online meeting

    In this webinar, Giovanni Briganti will introduce the field of AI in healthcare, starting from a scientific standpoint to clinical applications, as well as the promise and challenges that it entails for the Belgian Landscape.

  3. nani-chavez-EKHB_4kEYzw-unsplash.jpg
    24 March '22

    Healixia Annual Conference: Current and future trends in patient centric solutions for healthcare

    Diegem

    Healixia Annual Conference 2022: Current and future trends in patient centric solutions for healthcare.

Show all meetings

News

  1. January 21, 2022

    IFAPP Today newsletter - January 2022

    Source: IFAPP

    Please find here the link to the IFAPP TODAY newsletter of January 2022.

    Read more

  2. January 20, 2022

    PRAC January 2022 – Review of terlipressin medicines started, update of COVID-19 vaccins and new safety information for Mavenclad

    During its January 2022 meeting, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has started a referral of terlipressin medicines. The PRAC also has recommended a change to the product information for Vaxzevria and COVID-19 Vaccine Janssen. The PRAC discussed direct healthcare professional communication (DHPC) containing important safety information for Mavenclad.

    Source: FAMHP

    Read more

  3. January 20, 2022

    Manufacturers, importers and distributors of human and veterinary medicines must check their data in the Organisation Management Service database of the EMA

    From 28 January 2022, new regulations will come into force for manufacturers, importers and distributors of medicines for human and veterinary use. The FAMHP is asking them to check from 28 January 2022 onwards whether their organisation's data are correctly registered in the Organisation Management Service of the European Medicines Agency (EMA).

    Source: FAMHP

    Read more

We thank our partners for their support. Click on the logos for more information:
 
digidyco_clinical esolutions_gr_web2.png QbD_logo_RGB_300dpi logo Hebias web.png Modis 440x320 nieuwsbrief.jpg
jsn_logo_jj_vert_color_rgb.jpg 20201210 AxTalis Logo MAx MA.jpg SCIENCETALENTS_LOGO_RGB_POS.png Brookwood Global-website.png